Chaim Lebovits, President & CEO at Brainstorm Cell Therapeutics, holds 214.35K shares in Brainstorm Cell Therapeutics (Ticker: BCLI). Most recently, Chaim Lebovits Bought $23,836 shares of Brainstorm Cell Therapeutics on Oct 02, 2024 for an estimated value of 11.12K.
What is the percentage of profitable transactions made by Chaim Lebovits?
The percentage of profitable transactions made by Chaim Lebovits is ―.
What is the average return per transaction made by Chaim Lebovits?
The average return per transaction made by Chaim Lebovits is ―.
What stocks does Chaim Lebovits hold?
Chaim Lebovits holds: BCLI stocks.
What was Chaim Lebovits’s latest transaction?
Chaim Lebovits latest transaction was an Informative Buy of $11.12K.
What was Chaim Lebovits's most profitable transaction?
Chaim Lebovits’s most profitable transaction was an Informative Buy of BCLI stock on October 2, 2024. The return on the trade was -29.50%.
What is Chaim Lebovits's role in Brainstorm Cell Therapeutics?
Chaim Lebovits's role in Brainstorm Cell Therapeutics is President & CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.